McDermott, David,
Immune checkpoint blockade in renal cell carcinoma [electronic resource] / David McDermott. - London : Henry Stewart Talks, 2016. - 1 online resource (1 streaming video file (58 min.) : color, sound). - Immunotherapy of cancer, 2056-452X The kidney in health and disease, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Immunotherapy of cancer. Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Recent data that has led to the approval of PD-1 blockade in RCC -- Approaches to patient selection -- Novel combination therapies that are entering pivotal trials.
Access restricted to subscribers.
Mode of access: World Wide Web.
4211 Henry Stewart Talks
Antineoplastic agents.
Cancer--Immunological aspects.
Immunotherapy.
Kidneys--Cancer--Chemotherapy.
Kidneys--Cancer--Immunological aspects.
Renal cell carcinoma.
Antibodies, Monoclonal--therapeutic use.
Antineoplastic Agents--therapeutic use.
Carcinoma, Renal Cell--drug therapy.
Carcinoma, Renal Cell--immunology.
Cell Cycle Checkpoints.
Clinical Trials as Topic.
Combined Modality Therapy.
CTLA-4 Antigen--immunology.
Immunotherapy--methods.
Kidney Neoplasms--drug therapy.
Kidney Neoplasms--immunology.
Patient Selection.
Programmed Cell Death 1 Receptor--antagonists & inhibitors.
T-Lymphocytes--immunology.
Immune checkpoint blockade in renal cell carcinoma [electronic resource] / David McDermott. - London : Henry Stewart Talks, 2016. - 1 online resource (1 streaming video file (58 min.) : color, sound). - Immunotherapy of cancer, 2056-452X The kidney in health and disease, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Immunotherapy of cancer. Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Recent data that has led to the approval of PD-1 blockade in RCC -- Approaches to patient selection -- Novel combination therapies that are entering pivotal trials.
Access restricted to subscribers.
Mode of access: World Wide Web.
4211 Henry Stewart Talks
Antineoplastic agents.
Cancer--Immunological aspects.
Immunotherapy.
Kidneys--Cancer--Chemotherapy.
Kidneys--Cancer--Immunological aspects.
Renal cell carcinoma.
Antibodies, Monoclonal--therapeutic use.
Antineoplastic Agents--therapeutic use.
Carcinoma, Renal Cell--drug therapy.
Carcinoma, Renal Cell--immunology.
Cell Cycle Checkpoints.
Clinical Trials as Topic.
Combined Modality Therapy.
CTLA-4 Antigen--immunology.
Immunotherapy--methods.
Kidney Neoplasms--drug therapy.
Kidney Neoplasms--immunology.
Patient Selection.
Programmed Cell Death 1 Receptor--antagonists & inhibitors.
T-Lymphocytes--immunology.